JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 29, 2005; DOI: 10.1124/jpet.105.084236


0022-3565/05/3141-61-69$20.00
JPET 314:61-69, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084236v1
314/1/61    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reese, B. E.
Right arrow Articles by Yun, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reese, B. E.
Right arrow Articles by Yun, J.

TOXICOLOGY

Protein Kinase C{epsilon} Regulates Tumor Necrosis Factor-{alpha}-Induced Stannin Gene Expression

Brian E. Reese, Collin Davidson, Melvin L. Billingsley, and Jong Yun

Department of Pharmacology (B.E.R., C.D., M.L.B., J.Y.) and Jake Gittlen Cancer Research Institute (J.Y.), Penn State College of Medicine, Hershey, Pennsylvania

Stannin (Snn) is a highly conserved vertebrate protein that has been closely linked to trimethyltin (TMT) toxicity. We have previously demonstrated that Snn is required for TMT-induced cell death. Others have shown that TMT exposure results in tumor necrosis factor-{alpha} (TNF{alpha}) production and that TNF{alpha} treatment induces Snn gene expression in human umbilical vein endothelial cells (HUVECs). In this study, we investigated a signaling mechanism by which Snn gene expression is regulated by TMT and demonstrated that TNF{alpha} stimulates Snn gene expression in a protein kinase C{epsilon}-dependent manner in HUVECs in response to TMT exposure. Supporting this, we show that TMT-induced toxicity is significantly blocked by pretreatment with an anti-TNF{alpha} antibody in HUVECs. Using a quantitative real-time polymerase chain reaction assay, we also show that the level of Snn gene expression is significantly increased in HUVECs in response to either TMT or TNF{alpha} treatment. This TNF{alpha}-induced Snn gene expression is blocked when HUVECs were pretreated with bisindolylmaleimide I, an inhibitor of protein kinase C (PKC). In contrast, when HUVECs were treated with phorbol 12-myristate 13-acetate, a PKC activator, we observed a significant increase in Snn gene expression. Using isotype-specific siRNA against PKC, we further show that knockdown of PKC{epsilon}, but not PKC{delta} or PKC{zeta}, significantly blocked TNF{alpha}-induced Snn gene expression. Together, these results indicate that TNF{alpha}-induced, PKC{epsilon}-dependent Snn expression may be a critical factor in TMT-induced cytotoxicity.


Received January 27, 2005; accepted March 25, 2005.

Address correspondence to: Melvin Billingsley, Department of Pharmacology H078, 500 University Drive, Hershey, PA 17033. E-mail address: mlb8{at}psu.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.